FBRX
Forte Biosciences Inc
77.00$
+0.0%
vs. previous close
Closing price · As of: Aug 28, 2026
Statements
Cash Flow
Forte Biosciences Inc (FBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -51 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -21 | -30 | -31 | -34 | -2.8 | -18 | -17 | -8.2 | -29 | -31 | -51 | |
| 0.2 | 0.3 | 0.3 | 0.6 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| – | – | 4.5 | 6.9 | 0.0 | 1.0 | 4.2 | 4.0 | 3.3 | 3.1 | 6.3 | |
| – | – | – | 0.2 | 0.0 | 32 | 4.3 | – | – | – | – | |
| 0.7 | 1.9 | 2.5 | 6.1 | 1.3 | -3.8 | 0.7 | 1.7 | -0.4 | 1.8 | 11 | |
| 0.2 | 0.5 | 0.7 | 2.0 | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.1 | |
| -25 | 25 | -28 | -4.2 | -0.2 | 3.6 | – | – | 0.0 | -36 | 36 | |
| 33 | 3.4 | 0.1 | 29 | 8.2 | – | – | – | 0.0 | 0.0 | 0.0 | |
| – | – | – | 0.6 | – | – | – | – | – | – | – | |
| 50 | 2.3 | 89 | 44 | 4.9 | 67 | 0.0 | 7.2 | 25 | 52 | 69 | |
| 3.9 | -2.6 | 30 | 4.9 | -34 | 52 | -17 | -0.9 | -4.0 | -15 | 55 | |
| -21 | -30 | -32 | -36 | -2.9 | -18 | -17 | -8.2 | -29 | -31 | -51 |
Data as of: August 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.